And just like that, needle sticks vanish1


Grant patients* their wish for no needles






*For patients prescribed ZOMACTON 10 mg using ZOMA-Jet 10.



And just like that,
needle sticks vanish1

Grant patients*
their wish
for no needles

Experience the innovation of ZOMA-Jet 10 needle-free delivery


ZOMA-Jet 10 is more than just a needle-free device. It was designed to enhance the treatment experience and help meet the needs of patients.
With ZOMA-Jet 10:

  • Every dose is delivered completely needle free
  • Growth hormone is delivered quickly through the skin via an ultra-fine stream of fluid2
  • A more concentrated growth hormone* is used, which means less volume of liquid is administered compared with a previous needle-free device3

ZOMA-Jet effectively delivers ZOMACTON without the needle stick4

See ZOMACTON study data »

*ZOMACTON 10 mg

ZOMA-Jet 10 Delivery of GH Needle-based Delivery of GH

When given the option of treatment delivery, the majority of people chose needle free5

With ZOMA-Jet 10, you can give your patients the option of needle-free ZOMACTON delivery.

In a pooled analysis of 3 prospective observational studies, choice of delivery was documented for 658 patients. In the study, approximately 70% opted for needle-free delivery.5‡

In the first year, nearly 800 patients have used Needle-free ZOMA-Jet 10.

For patients prescribed ZOMACTON 10 mg.

Data of patients from 3 observational studies were evaluated in a pooled analysis that assessed the preference for needle-free devices. In a device cohort of patients whose exact delivery device was known, patients and their parents or legal guardians were free to choose their preferred type of delivery device: either a needle-injection device (needle injection or needle pen) or a needle-free device (ZOMA-Jet).5

§Data as of 10/04/2019.


With ZOMA-Jet 10, a barrier to adherence may vanish7

When helping patients reach their growth goals, every dose of growth hormone can make a difference. Unfortunately for some patients, the thought of a needle can turn treatment into a constant struggle. Patients may be less likely to miss a dose of their growth hormone if it was delivered without a needle.7

In a clinical study of more than 6000 children, patients were significantly more persistent with growth hormone therapy than those on needle-based treatment (P<0.0001).7ıı¶#

ııA retrospective cohort study of 6061 children aged ≤18 years at therapy initiation investigated medication persistence, growth hormone brand switches (identified as change to an alternative brand during the study period), and adherence. Patients received ZOMACTON via ZOMA-Jet (n=728) or 1 of 6 other brands of growth hormone delivered via needle-based devices.7

This information does not suggest or imply in any manner that any of the characteristics of each of the devices, alone, or in combination, are superior over another, nor is it intended to imply that the products or devices mentioned have comparable safety or efficacy, indications, and doses. Indications are not the same across products.

#Several ZOMA-Jet devices are available depending on the strength of ZOMACTON used. Authors did not specify which ZOMA-Jet was studied.

TREATMENT PERSISTENCE WITH ZOMA-JET VS
NEEDLE-BASED DEVICES7


Make a needle-free treatment experience a reality

Self-administration starts earlier with needle-free delivery7

The average age for self-administration was ~1½ years younger with ZOMA-Jet7

Being able to self-administer growth hormone can be a big step for patients and helpful for some families. In a retrospective study of more than 6000 patients ≤18 years old, those self-administering ZOMA-Jet were, on average, approximately 8½ years old, while patients self-administering with needle-based devices were approximately 10 years old.7#**

Self-administration starts earlier with needle-free delivery7

Being able to self-administer growth hormone can be a big step for patients and helpful for some families. In a retrospective study of more than 6000 patients ≤18 years old, those self-administering ZOMA-Jet were, on average, approximately 8½ years old, while patients self-administering with needle-based devices were approximately 10 years old.7#**





The average age for self-administration was ~1½ years younger with ZOMA-Jet7






ZOMA-Jet 10 requires ONE QUICK CLICK for dose delivery1

To help patients adhere to their growth hormone treatment, ZOMA-Jet 10 involves 3 routine steps for completely needle-free ZOMACTON delivery after your patient becomes familiar with the instructions for use.1


1. RIGHT: Turn right to reset to get ready for the next dose 2. LEFT: Turn left to fill the dose until the prescribed dose appears in the window 3. CLICK: Click to deliver the dose using the orange button, then reset
1. RIGHT: Turn right to reset to get ready for the next dose

2. LEFT: Turn left to fill the dose until the prescribed dose appears in the window

3. CLICK: Click to deliver the dose using the orange button, then reset



Download step-by-step instructions on how to use ZOMA-Jet 10 »


Rotate the administration site each time ZOMA-Jet 10 is used. See instructions for use for more details.

#Several ZOMA-Jet devices are available depending on the strength of ZOMACTON used. Authors did not specify which ZOMA-Jet was studied.

**Average age was 8.4 years old for ZOMA-Jet, and average age was 9.7 years old for needle-based devices.


Transform GH delivery into a completely needle-free experience

What could a completely needle-free somatropin experience mean to your patients? Because ZOMA-Jet 10 is needle free, it means eliminating concerns about needles, traveling with needles, and handling needles.1

The features of Zoma-Jet 10 include:

Absolutely no needles

With Needle-free ZOMA-Jet 10, growth hormone is delivered quickly through the skin via an ultra-fine stream of fluid2

Dial-back winding grip

The user can easily turn back the dosing dial to1:

  • Receive an accurate dose
  • Reduce wasted medicine

Reusable needle-free head

Each needle-free head can be used for up to 7 days1††

Easy viewing dosage window

Displays dosage for accurate dose delivery1

One-push dose-delivery button

The click lets parents and patients know that the medicine is delivered




Absolutely no needles
With Needle-free ZOMA-Jet 10, growth hormone is delivered quickly through the skin via an ultra-fine stream of fluid2

Reusable needle-free head
Each needle-free head can be used for up to 7 days1††

Easy viewing dosage window
Displays dosage for accurate dose delivery1






Dial-back winding grip
The user can easily turn back the dosing dial to1:

  • Receive an accurate dose
  • Reduce wasted medicine

One-push dose-delivery button
The click lets parents and patients know that the medicine is delivered





††The ZOMA-Jet 10 needle-free head must be discarded after 7 days in a FDA-cleared sharps disposal container after use. Discard other components in accordance with local or state laws. Do not throw away (dispose of) needle-free head in household trash.1

COMMITMENT TO COVERAGE

Because coverage is our priority, we have access programs designed to help your patients start and stay on ZOMACTON ‡‡

PERSONALIZED SUPPORT
FOR PATIENTS

ZoGo provides services related to your patients’ treatment with ZOMACTON

LEARN MORE GET DETAILS


‡‡As long as medically necessary.

COMMITMENT TO COVERAGE

Because coverage is our priority, we have access programs designed to help your patients start and stay on ZOMACTON ‡‡

LEARN MORE



PERSONALIZED SUPPORT
FOR PATIENTS

ZoGo provides services related to your patients’ treatment with ZOMACTON

GET DETAILS

‡‡As long as medically necessary.

References: 1. ZOMA-Jet 10 [instructions for use]. Parsippany, NJ: Ferring Pharmaceuticals Inc. 2. Al-Kaf AGA, Othman AM. A review of needle free injections. Univ J Pharm Res. 2017;2(2):1-6. 3. Kaptein AA. Transjecting growth hormone: continuous nightmare or controlled nuisance? Evaluation of a new needle-free device. Patient Prefer Adherence. 2013;703-708. 4. Agerso H, Moller-Pederson J, Cappi S, Thomann P, Jesussek B, Senderovitz T. Pharmacokinetics and pharmacodynamics of a new formulation of recombinant human growth hormone administered by ZomaJet 2 Vision, a new needle-free device, compared to subcutaneous administration using a conventional syringe. J Clin Pharmacol. 2002;42:1262-1268. 5. Rohrer TR, Ceplis-Kastner S, Jorch N. Needle-free and needle-based growth hormone therapy in children: a pooled analysis of three long-term observational studies. Horm Res Paediatr. 2018;90:393-406. 6. Data on file. 7. Spoudeas HA, Bajaj P, Sommerford N. Maintaining persistence and adherence with subcutaneous growth-hormone therapy in children: comparing jet-delivery and needle-based devices. Patient Prefer Adher. 2014;8:1255-1263.


PLEASE SEE IMPORTANT SAFETY INFORMATION AND FULL PRESCRIBING INFORMATION.
PLEASE SEE IMPORTANT SAFETY INFORMATION AND FULL PRESCRIBING INFORMATION.
+
PLEASE SEE IMPORTANT SAFETY INFORMATION AND FULL PRESCRIBING INFORMATION.
PLEASE SEE IMPORTANT SAFETY INFORMATION AND FULL PRESCRIBING INFORMATION.
-+